Search clinical trials for: MEDI4736 (Durvalumab) Tremelimumab
Total 787 results
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedMetastatic Anaplastic Thyroid CancerUnited States
-
MedImmune LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedMetastatic Colorectal CancerUnited States
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsJapan, Korea, Republic of, Taiwan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
AstraZenecaCompletedMetastatic Pancreatic Ductal AdenocarcinomaSpain, Canada, Korea, Republic of, Netherlands, United States, Germany
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
AstraZenecaRecruiting
-
Grupo Espanol de Tumores NeuroendocrinosMFARActive, not recruitingMetastatic Thyroid Cancer | Metastatic Thyroid Papillary Carcinoma | Metastatic Thyroid Follicular CarcinomaSpain
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Abramson Cancer Center at Penn MedicineCompletedMelanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)United States
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; MFARActive, not recruiting
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
MedImmune LLCCompletedMyelodysplastic SyndromeUnited States, United Kingdom, France, Germany
-
Grupo Espanol de Tumores NeuroendocrinosCompletedNeuroendocrine Tumors | Neuroendocrine Neoplasm of LungSpain
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...AstraZenecaActive, not recruitingAdvanced Biliary Tract CarcinomaFrance
-
AstraZenecaCompletedMelanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal CancerUnited States
-
Columbia UniversityWithdrawnNon-small Cell Lung Cancer
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaActive, not recruitingNonseminomatous Germ Cell Tumor | Seminoma | Germ Cell Tumor | Dysgerminoma | Pineal Germ Cell Tumor | Germinomatous Germ Cell TumorUnited States
-
Moshe OrnsteinCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Eli Lilly and CompanyAstraZenecaCompletedSolid TumorUnited States, Belgium, Israel, Czechia
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGermany
-
Davendra SohalRecruitingHepatocellular Carcinoma | Cirrhosis | Portal HypertensionUnited States
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZenecaRecruitingIntrahepatic CholangiocarcinomaGermany
-
European Organisation for Research and Treatment...CompletedColorectal Cancer | Liver MetastasesFrance, Netherlands, Switzerland, Germany, Austria, Sweden
-
AstraZenecaActive, not recruitingSmall Cell Lung CancerUnited States, Canada, Germany, Italy, Netherlands, Spain, Belgium, Poland, Taiwan, Vietnam, Korea, Republic of, Czechia, India, Japan, Russian Federation, Turkey, China, United Kingdom, Argentina
-
The University of Hong KongQueen Mary Hospital, Hong KongRecruitingHepatocellular CarcinomaHong Kong
-
Catherine ShuWithdrawnNonsmall Cell Lung CancerUnited States
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
Prisma Health-UpstateAstraZeneca; MedImmune LLCRecruitingCancer | Rare DiseaseUnited States
-
UNICANCERBreast International GroupCompletedBreast Cancer | Menopause | Estrogen Receptor Positive Tumor | Hormone AntagonistFrance, Sweden, Spain
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
NYU Langone HealthAstraZenecaWithdrawnPancreatic CancerUnited States
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States